What Is MOTS-c and What Science Studies

MOTS-c is a 16-amino-acid peptide encoded in mitochondrial DNA, specifically within the region of the 12S rRNA gene. Most peptides studied in biology are encoded in the nuclear genome. MOTS-c belongs to a distinct category called mitochondria-derived peptides, or MDPs. Mitochondria retained their own genome across evolutionary history, and that genome encodes at least a dozen bioactive peptides identified to date.

The significance of that origin comes down to proximity. Mitochondria regulate cellular energy production. A peptide encoded in that genome can act on that machinery without the intermediate signaling layers that mediate most nuclear-origin messengers. That directness is what drew early research attention to the MDP class in general and to MOTS-c specifically.

Discovery and Reference Studies

Lee et al. identified and characterized MOTS-c in a Cell Metabolism publication in 2015. The work documented that the peptide circulates in blood in both mice and humans, that circulating levels vary with age, and that MOTS-c activates the AMPK pathway. In murine models, experiments observed reduced visceral fat accumulation and improvements in insulin sensitivity parameters. Those results were obtained under controlled laboratory conditions. The authors drew no therapeutic conclusions.

In 2018, Kim et al. published an additional finding relevant to researchers in the field: under conditions of metabolic stress, MOTS-c can translocate from the cytoplasm into the cell nucleus and modify the expression of nuclear genes. A peptide of mitochondrial origin that regulates nuclear gene expression was a novel behavior relative to most MDPs described at that time, and it distinguished MOTS-c within the MDP class.

Subsequent work documented that circulating MOTS-c levels rise during high-intensity exercise in humans. That line of research is ongoing and has not reached consolidated conclusions.

Mechanism of Action According to Published Literature

The mechanism proposed in published studies involves inhibition of the folate-dependent hexosamine pathway. That inhibition raises the AMP/ATP ratio inside the cell, which activates AMPK — AMP-activated protein kinase, an enzyme that functions as a sensor of cellular energy balance.

When AMPK is active, it promotes processes that generate ATP: greater fatty acid oxidation, increased glucose uptake in skeletal muscle, and reduced lipid synthesis. The observation that a peptide encoded in the mitochondrial genome can activate that pathway selectively is the result that sustains scientific interest in MOTS-c and in the MDP class more broadly.

The studies that documented these mechanisms were conducted in cell models and in rodents. No advanced-phase clinical trial has evaluated MOTS-c as an intervention in humans.

Open Questions in Current Research

The literature identifies several areas that laboratories continue to work on:

• The relationship to aging: studies documented that MOTS-c levels decline with age in humans. Whether that decline is a cause, consequence, or epiphenomenon of cellular aging has not been established. The causal direction is unresolved.
• The role in exercise: more recent work showed that MOTS-c rises in circulation during high-intensity exercise. The mechanism by which contracting muscle elevates peptide levels — and what function that elevation serves — remains under investigation.
• Nuclear regulation: the 2018 finding on nuclear translocation raised questions about which genes MOTS-c regulates once inside the nucleus, and under what specific conditions that movement occurs.

None of these questions has a definitive answer in the current literature. That is part of what keeps MOTS-c an active research object rather than a closed chapter.

Molecular Structure and Compound Stability

MOTS-c carries the sequence MRWQEMGYIFYPRKLR. At 16 amino acids and a molecular weight of approximately 2.1 kDa, it is a short peptide. Compounds at that size are more susceptible to enzymatic degradation than longer polypeptides, which makes storage conditions a material consideration in laboratory protocol design.

The standard format for research supply is a lyophilized vial — freeze-dried powder — which offers greater stability during transport and storage than a reconstituted solution. Cold-chain handling is required to preserve compound integrity across the logistics chain.

Technical specifications for the available lot, including the full declared sequence and molecular weight, are listed on the MOTS-c product page.

Certificate of Analysis for the Available Lot

PeptoClinic supplies MOTS-c with analytical documentation from an independent laboratory. Janoshik Analytical analyzed the lot on April 13, 2026 (task 136923) and determined a purity of 99.669% by HPLC, with a measured content of 11.31 mg in a vial labeled as 10 mg.

Janoshik Analytical operates independently of PeptoClinic. The report is verifiable directly on their site. PeptoClinic publishes 99.669% because that is the figure on the report — not because it is the most favorable. It is the lowest purity figure in the catalogue, and it is the number that appears in the headline. The analytical documentation methodology that PeptoClinic applies to all lots is described on the quality page.

Research Use Only — Laboratory Material

MOTS-c is material for exclusive laboratory use, supplied under a Research Use Only (RUO) designation. PeptoClinic supplies it strictly for in vitro and laboratory research.

This compound is not approved and is not intended for human or veterinary consumption, diagnosis, or treatment of any medical condition. No regulatory authority — not the FDA, not ANMAT, nor any equivalent body — has evaluated MOTS-c for therapeutic or preventive use in people or animals.

PeptoClinic is not a pharmacy, a clinic, or a healthcare provider. No prescriptions are written or required. Inquiries about administration protocols for human use are not answered.

How to Request a Quote

PeptoClinic operates as a supply consultancy. There is no cart and no published price. A researcher or laboratory describes their requirements — compound, quantity, purity specification, required documentation, destination — and the technical team returns a written quote within one business day.

Argentina and the United States are active destinations. Material ships with cold-chain logistics and is documented for import as laboratory reference material. A quote can be initiated through the Argentina shipping page or by browsing the full catalogue.